BioCryst Pharmaceuticals

Ebitda Endring Dato
Gilead Sciences USD 2.73B 579M 2023-12
Intra Cellular Therapies USD -33961000 4.38M 2023-12
Ionis Pharmaceuticals USD -2924000 137.16M 2023-12
Roche Holding CHF 12.35B 1.92B 2023-06
Vertex Pharmaceuticals USD 1.08B 12.4M 2023-09



BioCryst Pharmaceuticals - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - May 2024.